Researchers at The Royal Marsden NHS Foundation Trust have found that routine whole-body MRI scans can reveal far more about multiple myeloma patient health than simply showing where their cancer is.
@healthcaretoday.bsky.social
@healthcaretoday.bsky.socialResearchers at The Royal Marsden NHS Foundation Trust have found that routine whole-body MRI scans can reveal far more about multiple myeloma patient health than simply showing where their cancer is.
@aiinmeditech.bsky.socialOur latest analysis explores how pharma companies can use oncology market sizing, therapy trends, competitive intelligence, and patient insights to identify high-potential markets.
Read more: www.sperresearch.com/Blogs/oncolo...
@bcc2026.bsky.socialBreast Cancer Congress 2027
June 17–18, 2027
Zurich, Switzerland
Join researchers, healthcare professionals, industry experts to share insights and advances in breast cancer research, patient care.
pinkribboncongress.com/registrations/
#BreastCancer #Oncology #CancerResearch #MedicalConference
@onclive.bsky.socialWATCH 🎥: Meredith Pelster, MD, MSCI, discusses the biomarker-agnostic design of the phase 3 MAPKeeper 301 trial of atebimetinib in metastatic pancreatic cancer. #pancsm #oncology
Full video ➡️: www.onclive.com/view/dr-pels...
@drjkyl.bsky.social📣Check out this new ResearchGate Editor pick from Technology in Cancer Research & Treatment editor Applonia Rose, PhD!
www.researchgate.net/journal/Tech...
#oncology #oncosky #medicalimaging #tumordetection #radiomics #AI
@onclive.bsky.social🎥 WATCH: Alexander N. Shoushtari, MD, of @mskcancercenter.bsky.social, discusses the current role, benefits, and limitations of monitoring ctDNA in metastatic uveal melanoma. #melsm #oncology
Full video ➡️: www.onclive.com/view/dr-shou...
@artera.aiWe’re kicking things off this Oct. 1–3 at Innovations in Urologic Practice and the Advances in Oncology Conference.
See where else you can find us throughout October. 👇
@sablesystems.bsky.social
@aliciaault.bsky.socialYet another study supporting the life-saving potential of vaccines.
@onclive.bsky.social🧬 Researchers at @wakeforestmed.bsky.social identified a protein that may help breast cancer spread to the brain and evade immune defenses. #bcsm #oncology
Read more ➡️: www.onclive.com/view/researc...
@dralhilali.comWhy does your oncologist ask about everyday activities such as shopping, working or getting out of bed?
Daily functioning offers important clues about how cancer is affecting you and how well you may cope with different treatments.
@onclive.bsky.social🔬 Benjamin Weinberg, MD, discusses the @fda.gov approval of daraxonrasib, RASolute 302 survival data, safety considerations, and the future of RAS-targeted therapies in pancreatic cancer. #pancsm #oncology
Read more ➡️: www.onclive.com/view/daraxon...
@drtimos.bsky.socialHow to win in #Oncology and #Hematology in 2025
📥 Get a FREE #LucidQuest Report http://dlvr.it/TVhmxL
🚀 Oncp/hema drug development is evolving fast. AI-driven Dx, novel MoAs & outcomes-based pricing are reshaping the landscape.
🏆 Who’s leading? AbbVie, Amgen, AZ, BMS, J&J & Novartis.
@bcc2026.bsky.socialBreast Cancer Congress 2027
June 17–18, 2027
Zurich, Switzerland | Online participation available
Hosted by Sciinov Group.
pinkribboncongress.com/abstract-submission/
#BreastCancer #Oncology #CancerResearch #BreastCancer2027 #BCC2027
@rcatanho.bsky.socialMás de una cuarta parte de los ensayos en oncología genitourinaria terminan prematuramente, a menudo por fallo de reclutamiento, asociada con características de la enfermedad, estructurales y operacionales #oncology #trials #failure ascopubs.org/doi/abs/10.1...
@nfbot.bsky.socialWATCH 🎥: Rebecca Brown, MD, discusses how the NCCN guideline inclusion of brigatinib is changing clinical practice for NF2-related schwannomatosis. #oncology www.onclive.com/view/dr-brow...
@onclive.bsky.social🔎 What happens after a cancer screening result comes back positive, but cancer isn’t found?
Jason Hafron, MD, of @oaklandu.bsky.social, discusses the often-overlooked burden of false positives and the need for more precise screening. #pcsm #oncology
Read more: www.onclive.com/view/calcula...
@onclive.bsky.socialWATCH 🎥: Rebecca Brown, MD, discusses how the NCCN guideline inclusion of brigatinib is changing clinical practice for NF2-related schwannomatosis. #oncology
@onclive.bsky.social